CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, placebo-controlled study but all study participants will receive the
active study medication at some point during the study for at least 12 weeks, and some
children with receive CBD for the entire study.